Exploiting senescence for the treatment of cancer
L Wang, L Lankhorst, R Bernards - Nature Reviews Cancer, 2022 - nature.com
Senescence is a cellular response to a variety of stress signals that is characterized by a
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
stable withdrawal from the cell cycle and major changes in cell morphology and physiology …
The pancreatic cancer genome revisited
A Hayashi, J Hong… - … reviews Gastroenterology & …, 2021 - nature.com
Pancreatic cancer is a genetic disease, and the recurrent genetic alterations characteristic of
pancreatic cancer indicate the cellular processes that are targeted for malignant …
pancreatic cancer indicate the cellular processes that are targeted for malignant …
[PDF][PDF] Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer
Here, we utilized spontaneous models of pancreatic and lung cancer to examine how
neoantigenicity shapes tumor immunity and progression. As expected, neoantigen …
neoantigenicity shapes tumor immunity and progression. As expected, neoantigen …
Every step of the way: integrins in cancer progression and metastasis
Cell adhesion to the extracellular matrix is fundamental to tissue integrity and human health.
Integrins are the main cellular adhesion receptors that through multifaceted roles as …
Integrins are the main cellular adhesion receptors that through multifaceted roles as …
Mutant p53: it's not all one and the same
MC Kennedy, SW Lowe - Cell Death & Differentiation, 2022 - nature.com
Mutation of the TP53 tumor suppressor gene is the most common genetic alteration in
cancer, and almost 1000 alleles have been identified in human tumors. While virtually all …
cancer, and almost 1000 alleles have been identified in human tumors. While virtually all …
Targeting mutant p53 for efficient cancer therapy
VJN Bykov, SE Eriksson, J Bianchi… - Nature Reviews Cancer, 2018 - nature.com
The tumour suppressor gene TP53 is the most frequently mutated gene in cancer. Wild-type
p53 can suppress tumour development by multiple pathways. However, mutation of TP53 …
p53 can suppress tumour development by multiple pathways. However, mutation of TP53 …
Tumor microenvironment participates in metastasis of pancreatic cancer
B Ren, M Cui, G Yang, H Wang, M Feng, L You… - Molecular cancer, 2018 - Springer
Pancreatic cancer is a deadly disease with high mortality due to difficulties in its early
diagnosis and metastasis. The tumor microenvironment induced by interactions between …
diagnosis and metastasis. The tumor microenvironment induced by interactions between …
Non-canonical functions of SNAIL drive context-specific cancer progression
MC Paul, C Schneeweis, C Falcomatà, C Shan… - Nature …, 2023 - nature.com
SNAIL is a key transcriptional regulator in embryonic development and cancer. Its effects in
physiology and disease are believed to be linked to its role as a master regulator of …
physiology and disease are believed to be linked to its role as a master regulator of …
Targeting metastasis
PS Steeg - Nature reviews cancer, 2016 - nature.com
Tumour metastasis, the movement of tumour cells from a primary site to progressively
colonize distant organs, is a major contributor to the deaths of cancer patients. Therapeutic …
colonize distant organs, is a major contributor to the deaths of cancer patients. Therapeutic …
[PDF][PDF] Senescence-induced vascular remodeling creates therapeutic vulnerabilities in pancreas cancer
KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic
response that promotes hypovascularity, immunosuppression, and resistance to chemo-and …
response that promotes hypovascularity, immunosuppression, and resistance to chemo-and …